$1,000 invested AbbVie Inc. (2016)
NYSE · ABBV · reinvest dividends · adjusted close
●Result2016-01-04 — 2026-09-11
Today you would have
$6,875
+$5,875 (+587.54%)
ABBVSPY (benchmark)
- Entry price
- $37.40
- Current price
- $257.12
- Shares
- 26.7399
- CAGR
- +19.77%
- Max Drawdown
- -45.09%
- vs SPY
- +237.71 pp
✦The story
A $1,000 position in AbbVie opened in January 2016 was worth $6,875 by July 2026, a total return of +587.5% versus +349.8% for the S&P 500. Over that decade AbbVie rode the peak years of Humira, one of the world's best-selling drugs, and built out its immunology and aesthetics portfolio, including the Allergan acquisition. The ride included a maximum drawdown of 45.1%.
#Related scenariosfor comparison
Other years for ABBV